Helen Rubinstein | Director, IR |
Barry Greene | CEO |
Jim Doherty | CDO |
Kimi Iguchi | CFO |
Chris Benecchi | CCO |
Andrea Tan | Goldman Sachs |
Tiffany Sun | JPMorgan |
Yasmeen Rahimi | Piper Sandler |
Laura Chico | Wedbush Securities |
Ami Fadia | Needham & Company |
Paul Matteis | Stifel |
Tazeen Ahmad | Bank of America |
Yatin Suneja | Guggenheim |
Douglas Tsao | H.C. Wainwright |
Matt Hagood | Oppenheimer |
Sumant Kulkarni | Canaccord |
Vikram Purohit | Morgan Stanley |
Good morning. Welcome to SAGE Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. Currently, all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of SAGE's website at sagerx.com. This call is the property of SAGE Therapeutics and recordings, reproduction, or transmissions of this call without the written consent of SAGE Therapeutics is strictly prohibited.